All News #Library
Others
Biogen Completes Acquisition of HI-Bio
03 Jul 2024 //
CONTRACT PHARMA
Hi-Bio Felzartamab Igan Positive: Phase 2 Ignaz Interim Results At Era
24 May 2024 //
PR NEWSWIRE
HI-Bio to Present at the 61st European Renal Association (ERA) Congress
29 Mar 2024 //
PR NEWSWIRE
HI-Bio Announces $95 Million Series B Financing
04 Jan 2024 //
PR NEWSWIRE
HI-Bio raises $95M as it pushes toward late-stage studies
04 Jan 2024 //
ENDPTS

Market Place
Sourcing Support